Company PEPTONIC medical AB

Equities

PMED

SE0005962206

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET 23:00:00 30/01/2024 GMT 5-day change 1st Jan Change
0.06 SEK -.--% Intraday chart for PEPTONIC medical AB -.--% +3.45%

Business Summary

Peptonic Medical AB is a Sweden-based company active in the field of biotechnology. The Company develops estrogen-free pharmaceuticals for treatment of vaginal atrophy. The Company's main drug candidate is Vagitocin, an oxytocin-based pharmaceutical preparation for the treatment of vaginal atrophy and other menopause-related symptoms. The patented treatment is based on local, vaginal application of oxytocin to rejuvenate the vaginal mucosa. Vagitocin is to enter phase III clinical trials in Europe and the United States.

Number of employees: 32

Sales per Business

SEK in Million2022Weight2023Weight Delta
Self-diagnostic Rapid Tests and Self-care Treatments
100.0 %
44 100.0 % 37 100.0 % -14.93%

Sales per region

SEK in Million2022Weight2023Weight Delta
Sweden
100.0 %
44 100.0 % 37 100.0 % -14.93%

Managers

Managers TitleAgeSince
Chief Executive Officer 54 13/04/21
Director of Finance/CFO - 20/10/23
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 64 31/12/08

Members of the board

Members of the board TitleAgeSince
Director/Board Member 55 23/05/23
Director/Board Member 55 -
Director/Board Member 58 23/05/22
Director/Board Member 43 -
Director/Board Member - 23/05/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,534,845,596 114,705,799 ( 7.473 %) 0 7.473 %

Company contact information

Peptonic Medical AB

Gustavslundsvägen 143

167 51, Bromma

+46 8 53 02 01 10

http://www.peptonicmedical.se
address PEPTONIC medical AB(PMED)
  1. Stock Market
  2. Equities
  3. PMED Stock
  4. Company PEPTONIC medical AB